AG00DDQN

52-86-8 | Haloperidol

Chemical structure of Haloperidol, CAS 52-86-8
AG00DDQN
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 52-86-8
Catalog Number AG00DDQN(AGN-PC-0SDTZI)
Chemical Name Haloperidol
IUPAC Name 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
InChI InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
InChI Key LNEPOXFFQSENCJ-UHFFFAOYSA-N
MDL Number MFCD00051423
Molecular Formula C21H23ClFNO2
Molecular Weight 375.8642
SMILES ClC1=CC=C(C=C1)C1(CCN(CC1)CCCC(=O)C1=CC=C(C=C1)F)O
UNII J6292F8L3D
Synonyms
Haldol, Haloperidol, haloperidol, 52-86-8, Haldol, Aloperidin, Serenace, Aloperidol, Brotopon, Eukystol, Einalon S, Aloperidolo, Galoperidol, Halojust, Halopoidol, Serenase, Serenelfi, Ulcolind, Uliolind, Vesalium, Halopal, Linton, Mixidol, Pernox, Sernas, Sernel, Dozic, Aldo, Lealgin compositum, Keselan, Peluces, Bioperidolo, Haloperidolum, Sigaperidol, Haldol Solutab, McN-JR-1625, Aloperidon, Fortunan, Halosten, Aloperidolo [DCIT], Halidol, Halopidol, Pekuces, Halol, Aloperidolo [Italian], 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one, Haloperidolum [INN-Latin], NSC 170973, R 1625, R-1625, C21H23ClFNO2, 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine, UNII-J6292F8L3D, CCRIS 1630, Haloperidol (Haldol), 4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone, 4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone, HSDB 3093, Haloperidol lactate, CHEMBL54, EINECS 200-155-6, Haldol (TN), NSC 615296, 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone, BRN 0331267, 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-, 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, MLS000028450, CHEBI:5613, LNEPOXFFQSENCJ-UHFFFAOYSA-N, 4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone, 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, J6292F8L3D, Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-, 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-, 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one, NSC170973, NSC615296, CAS-52-86-8, NCGC00015500-10, SMR000058303, 4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone, 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone, Haloperidol Intensol, 4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone, Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-, gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one, DSSTox_CID_14150, DSSTox_RID_79117, DSSTox_GSID_34150, 61788-97-4, W-105791, Haloperido, Peridol, Dozix, Apo-Haloperidol, Pms Haloperidol, Novo-Peridol, Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-, gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, Haldol La, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one, SR-01000003076, Haloperidol [USAN:INN:BAN:JAN], Duraperidol, Resin epoxy, 4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone, gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone, 4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, Picroside-III, Haloperidol, 1, Haloperidol, powder, Haloperidol(Haldol), Prestwick_250, Phenolic epoxy resin, Haloperidol [USAN:USP:INN:BAN:JAN], MDMO-PPV, Spectrum_000861, Tocris-0931, Opera_ID_446, 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl), Prestwick0_000115, Prestwick1_000115, Prestwick2_000115, Prestwick3_000115, Spectrum2_001268, Spectrum3_000448, Spectrum4_000570, Spectrum5_000788, Lopac-H-1512, Biomol-NT_000035, GTPL86, Probes1_000255, Probes2_000296, H 1512, AC1L1G7K, SCHEMBL8264, Lopac0_000583, Oprea1_509923, BSPBio_000130, BSPBio_002096, KBioGR_000980, KBioGR_002390, KBioSS_001341, KBioSS_002395, 5-21-02-00377 (Beilstein Handbook Reference), MLS001146904, BIDD:GT0128, DivK1c_000654, SPECTRUM1500325, SPBio_001236, SPBio_002069, McM-JR-1625, AC1Q77Z0, BPBio1_000144, BPBio1_001231, Haloperidol (JP17/USP/INN), DTXSID4034150, BDBM21398, HMS502A16, KBio1_000654, KBio2_001341, KBio2_002390, KBio2_003909, KBio2_004958, KBio2_006477, KBio2_007526, KBio3_001316, KBio3_002869, LNEPOXFFQSENCJ-UHFFFAOYSA-, AOB5645, cMAP_000037, NINDS_000654, AC250, HMS1568G12, HMS1920D03, HMS2089M15, HMS2091J09, HMS2095G12, HMS2234P08, HMS3261F08, HMS3370H11, HMS3657I13, HMS3712G12, Pharmakon1600-01500325, ZINC537822, Haloperidol 1.0 mg/ml in Methanol, Tox21_110162, Tox21_300475, Tox21_500583, A0H334, BG0211, CCG-36042, CCG-39111, IN1474, MFCD00051423, NSC757054, STL417208, AKOS000280660, Tox21_110162_1, API0002885, CS-1971, DB00502, LP00583, MCULE-3693790133, NSC-170973, NSC-615296, NSC-757054, IDI1_000654, MRF-0000027, QTL1_000042, WLN: T6NTJ A3VR DF& DQ DR DG, NCGC00015500-01, NCGC00015500-02, NCGC00015500-03, NCGC00015500-04, NCGC00015500-05, NCGC00015500-06, NCGC00015500-07, NCGC00015500-08, NCGC00015500-09, NCGC00015500-11, NCGC00015500-12, NCGC00015500-13, NCGC00015500-14, NCGC00015500-15, NCGC00015500-16, NCGC00015500-17, NCGC00015500-19, NCGC00016234-01, NCGC00023875-02, NCGC00023875-04, NCGC00023875-05, NCGC00023875-06, NCGC00023875-07, NCGC00023875-08, NCGC00023875-09, NCGC00254503-01, NCGC00261268-01, 177716-59-5, AC-19691, AN-41634, CC-16450, HY-14538, LS-48311, SC-81035, ACM1189986591, SBI-0050565.P004, AB2000375, SC 170973, TR-018722, AB00052008, EU-0100583, FT-0669100, FT-0697842, N1910, S1920, ST50319916, SW196557-4, W0039, 4763-EP2269989A1, 4763-EP2269990A1, 4763-EP2272537A2, 4763-EP2272972A1, 4763-EP2272973A1, 4763-EP2275420A1, 4763-EP2277872A1, 4763-EP2277876A1, 4763-EP2292614A1, 4763-EP2295061A1, 4763-EP2295412A1, 4763-EP2295413A1, 4763-EP2295439A1, 4763-EP2298731A1, 4763-EP2298776A1, 4763-EP2305260A1, 4763-EP2308867A2, 4763-EP2308870A2, 4763-EP2311801A1, 4763-EP2311803A1, 4763-EP2311824A1, 4763-EP2311837A1, 4763-EP2316834A1, C01814, D00136, VU0239704-10, AB00052008-21, AB00052008-22, AB00052008_23, AB00052008_24, C-35402, L000288, SR-01000003076-2, SR-01000003076-8, BRD-K67783091-001-04-8, BRD-K67783091-001-05-5, BRD-K67783091-003-03-6, I14-13404, I14-14165, SR-01000003076-11, Haloperidol, European Pharmacopoeia (EP) Reference Standard, Poly[2-methoxy-5-(3,7-dimethyoctyoxyl)-1,4-phenylenevinylene], .gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone, Haloperidol, United States Pharmacopeia (USP) Reference Standard, .gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, 4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-one, Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material, 4-[4-(4-Chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)- 1-butanone, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone, Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard, Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard, Haloperidol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2, haloperin, Neurodol, Picroside III, haloperidol-, Epoxy resins, Haldol decanoate, Haloperidol D4, Aloperidin (TN), Bioperidolo (TN), Duraperidol (TN), Sigaperidol (TN), Brotopon (TN), Eukystol (TN), Halosten (TN), Serenace (TN), Serenase (TN), Keselan (TN), Peluces (TN), Linton (TN), Einalon S (TN), Dozic (TN), Haloperidol (JP15/USP), D0D1AL, HALOPERIDOL DECANOATE, McN-JR 1625, CHEMBL545608, Haloperidol (JP15/USP/INN), CID3559, C21-H23-Cl-F-N-O2, Haloperidol [USAN:BAN:INN:JAN], AC-250, CS-T-25844, B2099, H0912, A10446, D006220, 64461-95-6, 1-(3-p-Fluorobenzoylpropil)-4-p-clorofenil-4-hidroxipiperidine 4, Aloperidin;Bioperidolo;Brotopon;Dozic;Duraperidol;Einalon S;Haldol, gamma-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone, 4-(4-Hydroxy-4''''-chloro-4-phenylpiperidino)-4''''-fluorobutyrophenone, 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4''''-fluorobutyrophenone, Butirofenona, 4-[4-(p-clorofenil)-4-] hidroxipiperidino-4'-fluoro-, 1-butanona, 4-[4-(4-clorofenil)-4-hidroxi-1-piperidinil]-1-(4-fluorofenil)-, 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)-, Butyrophenone 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-(6CI8CI), 1189986-59-1, GMJ,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited